Urs W. Von Holzen

Surgical Oncology
200 High Park Ave
Goshen, IN 46526

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Targeting the c-Met/VEGFR Pathway to Boost Nab-Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights.

Targeting the c-Met/VEGFR Pathway to Boost Nab-Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights.

Journal: Cells
Published: December 11, 2025

Synergistic Disruption of Survival and Metastatic Potential in Esophageal Adenocarcinoma Cells Through Combined Inhibition of HIF1α and CD73.

Synergistic Disruption of Survival and Metastatic Potential in Esophageal Adenocarcinoma Cells Through Combined Inhibition of HIF1α and CD73.

Journal: Cancers
Published: October 25, 2025

Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.

Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.

Journal: International journal of molecular sciences
Published: September 17, 2025

Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma.

Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma.

Journal: Cancers
Published: August 12, 2024

Mediastinal Intrathymic Parathyroid Adenoma: A Case Report and Review of the Literature.

Mediastinal Intrathymic Parathyroid Adenoma: A Case Report and Review of the Literature.

Journal: Cureus
Published: July 22, 2023

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and Safety.

Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers-Improvements in Clinical Efficacy and Safety.

Journal: Biomedicines
Published: May 17, 2023

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review).

Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review).

Journal: Oncology reports
Published: January 30, 2023

National Economic Conditions May Impact the Financial Barriers to Travel for Cancer Operations.

National Economic Conditions May Impact the Financial Barriers to Travel for Cancer Operations.

Journal: Annals of surgery open : perspectives of surgical history, education, and clinical approaches
Published: July 29, 2022

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer.

Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: April 20, 2022

Efficacy of intraoperative cholangiography versus preoperative magnetic resonance cholangiography in patients with intermediate risk for common bile duct stones.

Efficacy of intraoperative cholangiography versus preoperative magnetic resonance cholangiography in patients with intermediate risk for common bile duct stones.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: January 12, 2022

Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models.

Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models.

Journal: Cancer biology & therapy
Published: December 09, 2021

Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling.

Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt/beta-catenin signaling.

Journal: Journal of pineal research
Published: November 22, 2021
Showing 1-12 of 53

Last Updated: 09/26/2026